Literature DB >> 25598410

The common link between functional somatic syndromes may be central sensitisation.

Julius H Bourke1, Richard M Langford2, Peter D White3.   

Abstract

OBJECTIVES: Functional somatic syndromes are common and disabling conditions that all include chronic pain, and which may be related to central nervous system sensitisation. Here, we address the concept of central sensitisation as a physiological basis for the functional somatic syndromes.
METHODS: A narrative review of the current literature on central sensitisation and physiological studies in the functional somatic syndromes.
RESULTS: Central sensitisation may be a common neurophysiological process that is able to explain non-painful as well as painful symptoms in these disorders. Furthermore, central sensitisation may represent an endophenotypic vulnerability to the development of these syndromes that potentially explains why they cluster together.
CONCLUSIONS: Further research is needed to verify these findings, including prospective studies and the standardisation of combined methods of investigation in the study of central sensitisation in functional somatic syndromes. In turn, this may lead to new explanatory mechanisms and treatments being evaluated. Our conclusions add to the debate over the nomenclature of these syndromes but importantly also provide an explanation for our patients.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Central sensitisation; Chronic pain; Functional somatic syndromes; Neurophysiology; Pathophysiology

Mesh:

Year:  2015        PMID: 25598410     DOI: 10.1016/j.jpsychores.2015.01.003

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  30 in total

1.  Performance of the American College of Rheumatology 2016 criteria for fibromyalgia in a referral care setting.

Authors:  Sakir Ahmed; Amita Aggarwal; Able Lawrence
Journal:  Rheumatol Int       Date:  2019-05-17       Impact factor: 2.631

2.  Medically unexplained symptoms: assessment and management.

Authors:  Mujtaba Husain; Trudie Chalder
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

3.  [Psychosocial stressors and pain sensitivity in chronic pain disorder with somatic and psychological factors (F45.41)].

Authors:  M Studer; J Stewart; N Egloff; E Zürcher; R von Känel; J Brodbeck; M Grosse Holtforth
Journal:  Schmerz       Date:  2017-02       Impact factor: 1.107

4.  Emotional Awareness and Expression Interview: Examining Interview Content and Patient Experiences in Two Medical Samples.

Authors:  Shoshana Krohner; Jolin B Yamin; Maisa S Ziadni; Jennifer N Carty McIntosh; Howard Schubiner; Mark A Lumley
Journal:  J Clin Psychol Med Settings       Date:  2022-10-03

Review 5.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

Review 6.  Persistent dentoalveolar pain disorder: A putative intraoral chronic overlapping pain condition.

Authors:  Alberto Herrero Babiloni; Donald R Nixdorf; Estephan J Moana-Filho
Journal:  Oral Dis       Date:  2019-12-17       Impact factor: 3.511

7.  Multiple functional gastrointestinal disorders linked to gastroesophageal reflux and somatization: A population-based study.

Authors:  R S Choung; G Richard Locke; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2017-03-03       Impact factor: 3.598

Review 8.  Quantitative sensory testing and predicting outcomes for musculoskeletal pain, disability, and negative affect: a systematic review and meta-analysis.

Authors:  Vasileios Georgopoulos; Kehinde Akin-Akinyosoye; Weiya Zhang; Daniel F McWilliams; Paul Hendrick; David A Walsh
Journal:  Pain       Date:  2019-09       Impact factor: 7.926

9.  A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.

Authors:  Caroline M Kopruszinski; Edita Navratilova; Juliana Swiokla; David W Dodick; Iain P Chessell; Frank Porreca
Journal:  Cephalalgia       Date:  2020-09-26       Impact factor: 6.292

10.  Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain.

Authors:  Edita Navratilova; Guangchen Ji; Caroline Phelps; Chaoling Qu; Matthew Hein; Vadim Yakhnitsa; Volker Neugebauer; Frank Porreca
Journal:  Pain       Date:  2019-04       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.